Dr. Obeidat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-5200Fax+1 414-259-0469
Summary
- I am a board-certified neurologist who specializes in neuroimmunology and multiple sclerosis.
Education & Training
- University of Cincinnati Medical Center Inc.Fellowship, Neuroimmunology & Multiple Sclerosis, 2017 - 2018
- University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 2014 - 2017
- Wright State UniversityPh.D., Biomedical Sciences (Neuroscience and Physiology), With High Honors, 2009 - 2013
- Jordan University of Science and Technology FOMClass of 2008
Certifications & Licensure
- WI State Medical License 2018 - 2025
- OH State Medical License 2017 - 2021
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Best in Class PRIME’s GME Today Advance Practice in Multiple Sclerosis, 2016
- International Junior Investigator Award 2016
- Resident Scholar Award for Young Trainee with Ongoing and Significant Interest in Multiple Sclerosis Foundation of the Consortium of Multiple Sclerosis Centers, 2015
- Join now to see all
Clinical Trials
- Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis Start of enrollment: 2019 Oct 28
Roles: Contact
Publications & Presentations
PubMed
- Corrigendum to "Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels are B cell depletion with Ocrelizumab" [J. N...Cody J Gurski, Zivar Hajiyeva, Anthony J Veltri, Kaylan Fenton, Samantha O'Dell
Journal of Neuroimmunology. 2024-12-27 - Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels after B cell depletion with Ocrelizumab.Cody J Gurski, Zivar Hajiyeva, Anthony J Veltri, Kaylan Fenton, Samantha O'Dell
Journal of Neuroimmunology. 2024-12-02 - JC virus or extended interval dosing? More data are needed.Ahmed Z Obeidat
Multiple Sclerosis. 2024-11-01
Journal Articles
- Fragile ScreamAhmed Z Obeidat, Neurology 90.9 (2018): 427-427., 2/27/2018
Abstracts/Posters
- The Status of Multiple Sclerosis and Neuroimmunology Fellowship Training in the United States: A Pilot StudyObeidat AZ, Ramirez R, Halper J, Multiple Sclerosis Journal, 1/1/2017
- The 10-Point Disability Scale in Multiple Sclerosis: Phase I Development and Planning studyObeidat AZ, Multiple Sclerosis Journal, 1/1/2017
- Clinical Features of Sarcoid Patients With Ischemic StrokeObeidat AZ, Sucharew H, Moomaw CJ, Kleindorfer DO, Kissela BM, Alwell K, Flaherty ML, Broderick JP, Woo D, International Stroke Conference, Los Angeles, CA, 1/1/2016
- Join now to see all
Other
- New Insights into the Spinal Recurrent Inhibitory Pathway Normally and after Motoneuron RegenerationObeidat, AZ, Doctoral Dissertation
Wright State University - Article on Wright State University website about researchObeidat AZ, Local Media Appearance
https://webapp2.wright.edu/web1/newsroom/2012/10/19/spinal-cord-circuit-that-controls-body-movement-focus-of-wright-state-neuroscience-research/ - Immunotherapy responsive seizuresObeidat, AZ, E-Pearl on Neurology Podcast
www.neurology.org
1/23/2015
Authored Content
- Balloons of Hope7/19/2018
Press Mentions
- The Medical College of Wisconsin’s Top Featured Stories of 2024December 19th, 2024
- Marquette University Biomedical Engineering Professor Receives $3.34 Million R01 Grant to Study Improved Mobility for Those With Multiple SclerosisOctober 11th, 2022
- High Density of MS Patients in Wisconsin -- but Why?June 9th, 2022
- Join now to see all
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: